Glucagon-Like Peptide 1 (GLP-1) Receptor Variants and Glycemic Response to Liraglutide: A Pharmacogenetics Study in Iranian People with Type 2 Diabetes Mellitus.

Maryam EghbaliFariba Alaei-ShahmiriNahid Hashemi-MadaniZahra EmamiLadan MostafaviMojtaba MalekMohammad Ebrahim Khamseh

Published in: Advances in therapy (2024)

GLP-1R rs10305420 polymorphism can explain some of the inter-individual differences in glycemic response to liraglutide in a population of Iranian people with T2DM.

Keyphrases

type diabetes
glycemic control
dna methylation
genome wide